Generative AI (GenAI) has emerged as a groundbreaking innovation in healthcare analytics, revolutionizing the way life sciences organizations harness real-world data (RWD). However, simply deploying an AI-powered solution is not enough. To truly maximize the potential of GenAI, companies must ensure it offers a user-friendly experience, aligns with regulatory standards, and meets the needs of commercial and clinical teams. This article delves into the essential considerations for evaluating a GenAI solution, emphasizing the importance of ease of use, data agnosticism, regulatory compliance, and transparency. By asking the right questions and partnering with the right technology providers, life sciences companies can unlock the full value of GenAI and drive impactful insights in the pharmaceutical industry.
Read more from biopharmadive.com